To allow an expansion project, Evonik will shut down its Singapore methionine plant
Evonik has recently announced updates regarding the expansion of its DL-methionine production facility based in Singapore. The company is planning to shut down its Jurong Island plant to facilitate the construction process. This shutdown is expected to take place for a duration of three months in the fourth quarter of 2023 and will be followed by another three months of shutdown in the first half of 2024.
Request Access For the Latest Price Trends of DL-methionine
The company will be implementing this strategic shutdown of its methionine asset in order to ensure long-term global supply security. As part of their expansion plans, this shutdown is necessary for the modifications of their facilities that cannot be completed during regular operations due to safety and maintenance reasons. The planned production stops in the fourth quarter of 2023, and the first half of 2024 will provide the ideal opportunity for these modifications to be made.
Evonik is a renowned company that specializes in the production of specialty chemicals. The company has branches in over 100 countries and has managed to achieve remarkable success, earning Euro 18.5 billion in sales and a profit of Euro 2.49 billion in the year 2022. The company is committed to delivering innovative, profitable, and sustainable solutions to its consumers, and its workforce of 34,000 individuals is driven by a common goal of improving life today and in the future.
Methionine is an essential compound for the production of livestock which ensures the growth and development of animals. The production of livestock depends on methionine due to its ability to provide healthy, efficient, and sustainable feed for animals. Evonik's science-based approach develop innovative product and services in the business line of animal nutrition to ensure that the livestock industry can meet the increasing demand for animal protein.
Read More About DL-methionine Production Cost Reports - Get Free Sample Copy in PDF
According to Regional Vice President of Animal Nutrition Noel Kim, the recent temporary closures may be challenging for their clients to meet the demand for livestock. However, he ensured their team would implement effective measures to address potential supply issues.
According to Procurement Resource, Evonik is planning to expand its DL-methionine manufacturing unit based in Singapore. To facilitate the construction work for this expansion, the company plans to shut down this unit for three months in the fourth quarter of 2023 and another three months in the first half of 2024.
